Home › Stocks › SXTP

SXTP — 60 DEGREES PHARMACEUTICALS I

Reported value held$1.01M
Funds holding (latest)28
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)8
Institutional value$578.50K · 434.97K sh
New / Add / Cut / Exit2 / 2 / 1 / 3 · Updated 2026-11-21
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +37.3% (+118.14K sh)
Institutional value change Up +3.8%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
$906,610 -3.9% -$8.3M — -991.6% -41.8% -1096.4% — — — —

Revenue YoY trend    Net margin trend

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingHold
Analysts covering2
12-month price target$3.70 (+587.9%)
Last price at fetch$0.54
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)+0.00
Revision score (year)+0.00
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -0.78 — -0.67 -0.89 2 —
Mar 2027 -0.90 — -0.90 -0.90 1 —
Jun 2027 -0.88 — -0.88 -0.88 1 —
Sep 2027 -0.91 — -0.91 -0.91 1 —
Dec 2027 -0.89 — -0.89 -0.89 1 —
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -3.31 — -3.16 -3.45 2 —
Dec 2027 -2.14 — -0.70 -3.58 2 —
Dec 2028 -0.60 — -0.60 -0.60 1 —

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 8 SEC-registered investment managers reported holding SXTP (60 DEGREES PHARMACEUTICALS I) in their latest 13F filings, with a combined reported value of $578.50K across 434.97K shares. That is +37.3% by share count (+118.14K shares) versus the previous quarter, while reported value moved +3.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 2 opened new positions, 2 added to existing stakes, 1 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of 60 DEGREES PHARMACEUTICALS I (SXTP) include Kathmere Capital Management, LLC, ARMISTICE CAPITAL, LLC, Walleye Capital LLC, ranked by reported 13F value among the 28 institutional holders on this page.

SXTP is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 8 434.97K $578.50K +37.3%
Q2 2026 9 363.87K $640.41K +51.5%
Q1 2026 8 194.33K $340.07K +219.1%
Q4 2025 7 44.36K $22.55K +20.9%
Q3 2025 6 17.38K $25.59K +12.8%
Q2 2025 5 15.24K $36.12K -48.8%
Q1 2025 6 30.05K $54.81K -30.4%
Q4 2024 9 153.69K $198.03K +314.0%

Over the 8 quarters shown, institutional share counts increased 183% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+314.0%).

Top Institutional Holders (Q3 2026) — 8 funds

FundSharesValuePortfolio WeightChange
Kathmere Capital Management, LLC 390.95K $519.97K 0.03% Add
Geode Capital Management 14.55K $19.35K 0.00% Hold
Citadel Advisors 14.29K $19.00K 0.00% Reduce
UBS Group AG 13.53K $17.99K 0.00% Hold
BARCLAYS PLC 1.48K $1.96K 0.00% Add
Robinhood Markets, Inc. 84 $110 0.00% New
Tower Research Capital LLC (TRC) 64 $85 0.00% New
OSAIC HOLDINGS, INC. 25 $33 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 9 funds

FundSharesValuePortfolio WeightChange
Kathmere Capital Management, LLC 265.10K $466.58K 0.03% Add
Citadel Advisors 22.36K $39.36K 0.00% New
XTX Topco Ltd 17.64K $31.05K 0.00% New
Kovack Advisors, Inc. 15.00K $26.40K 0.00% New
GEODE CAPITAL MANAGEMENT, LLC 14.55K $25.61K 0.00% New
Geode Capital Management 14.55K $25.61K 0.00% Reduce
UBS Group AG 13.59K $23.92K 0.00% Reduce
BARCLAYS PLC 1.05K $1.85K 0.00% Reduce
OSAIC HOLDINGS, INC. 25 $44 0.00% Hold

Q1 2026 — 8 funds

FundSharesValuePortfolio WeightChange
Kathmere Capital Management, LLC 144.68K $253.19K 0.02% New
UBS Group AG 31.41K $54.97K 0.00% Add
Geode Capital Management 16.30K $28.52K 0.00% Add
BARCLAYS PLC 1.86K $3.25K 0.00% Add
NewEdge Advisors, LLC 50 $88 0.00% New
OSAIC HOLDINGS, INC. 25 $43 0.00% Reduce
TWIN PEAKS WEALTH ADVISORS, LLC 8 $14 0.00% New
Citigroup Inc 1 $2 0.00% New

Q4 2025 — 7 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 22.05K $11.21K 0.00% New
Geode Capital Management 12.45K $6.33K 0.00% Hold
Tower Research Capital LLC (TRC) 6.74K $3.42K 0.00% Add
BARCLAYS PLC 1.51K $769 0.00% New
UBS Group AG 1.48K $750 0.00% Hold
OSAIC HOLDINGS, INC. 100 $51 0.00% Hold
Bank of America Corp 31 $16 0.00% Add

Q3 2025 — 6 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 12.45K $18.30K 0.00% Reduce
Tower Research Capital LLC (TRC) 3.14K $4.65K 0.00% Add
UBS Group AG 1.48K $2.18K 0.00% Add
Citigroup Inc 189 $278 0.00% New
OSAIC HOLDINGS, INC. 100 $141 0.00% Hold
Bank of America Corp 30 $44 0.00% Add

Q2 2025 — 5 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 12.52K $29.66K 0.00% Add
Tower Research Capital LLC (TRC) 2.60K $6.16K 0.00% Add
OSAIC HOLDINGS, INC. 100 $237 0.00% Hold
UBS Group AG 14 $33 0.00% Reduce
Bank of America Corp 13 $30 0.00% Add

View all 28 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Kathmere Capital Management, LLC 390.95K 265.10K 144.68K — — — — — — — — — —
Geode Capital Management 14.55K 14.55K 16.30K 12.45K 12.45K 12.52K 11.92K — — 38.00K — — —
Citadel Advisors 14.29K 22.36K — — — — — — 10.10K — 100.63K — 22.19K
UBS Group AG 13.53K 13.59K 31.41K 1.48K 1.48K 14 16.19K 20.41K 3.31K 34.48K — — —
BARCLAYS PLC 1.48K 1.05K 1.86K 1.51K — — — — — — — — —
Robinhood Markets, Inc. 84 — — — — — — — — — — — —
Tower Research Capital LLC (TRC) 64 — — 6.74K 3.14K 2.60K 1.55K 3.73K 1.47K 7.09K 6.92K 3.08K 3.00K
OSAIC HOLDINGS, INC. 25 25 25 100 100 100 100 500 — — — — —
CENTRAL BANK & TRUST CO — — — — — — — — — 167.00K 268.00K 357.00K 468.00K
ARMISTICE CAPITAL, LLC — — — — — — — 98.93K — — — — —
Walleye Capital LLC — — — — — — — — — — — 102.62K 139.30K
XTX Topco Ltd — 17.64K — — — — — — — — — — —
Kovack Advisors, Inc. — 15.00K — — — — — — — — — — —
GEODE CAPITAL MANAGEMENT, LLC — 14.55K — — — — — — — — — — —
TWO SIGMA SECURITIES, LLC — — — — — — — 15.44K — 17.20K 24.19K — —
Virtu Financial LLC — — — — — — — — 12.68K 45.14K 59.52K — 14.49K
HRT FINANCIAL LP — — — — — — — 12.59K — 28.79K — — —
JANE STREET GROUP, LLC — — — 22.05K — — — — — — — — —
NATIONAL BANK OF CANADA /FI/ — — — — — — — — 4.00K — — — —
SUSQUEHANNA INTERNATIONAL GROUP, LLP — — — — — — — — — 13.30K 13.54K — —

Download holders (CSV)

FAQ

Which funds hold SXTP?

As of 2026-Q3, 8 institutional funds reported holding SXTP (60 DEGREES PHARMACEUTICALS I) in SEC 13F filings, with a combined reported value of $578.50K.

How many shares of SXTP do institutions own?

13F filers reported 434.97K shares of SXTP, worth $578.50K in aggregate at the end of 2026-Q3.

Is institutional ownership of SXTP rising or falling?

Share counts moved +37.3% versus the prior quarter — accumulation.

Who are the top institutional holders of SXTP?

The largest 13F holders are Kathmere Capital Management, LLC, ARMISTICE CAPITAL, LLC, Walleye Capital LLC, CENTRAL BANK & TRUST CO, XTX Topco Ltd; the top 25 are ranked at the top of this page.

Who are the major shareholders of 60 DEGREES PHARMACEUTICALS I?

The major shareholders of 60 DEGREES PHARMACEUTICALS I (SXTP) by reported 13F value are Kathmere Capital Management, LLC, ARMISTICE CAPITAL, LLC, Walleye Capital LLC, CENTRAL BANK & TRUST CO, XTX Topco Ltd, among 28 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own SXTP" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/SXTP/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →